Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats

BACKGROUND: Cyclosporin A (CsA) is a promising therapeutic drug for myocardial ischemia reperfusion injury (MI/RI) because of its definite inhibition to the opening of mitochondrial permeability transition pore (mPTP). However, the application of cyclosporin A to treat MI/RI is limited due to its im...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chang-xiong, Cheng, Ying, Liu, Dao-zhou, Liu, Miao, Cui, Han, Zhang, Bang-le, Mei, Qi-bing, Zhou, Si-yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346555/
https://www.ncbi.nlm.nih.gov/pubmed/30683110
http://dx.doi.org/10.1186/s12951-019-0451-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346555/
https://www.ncbi.nlm.nih.gov/pubmed/30683110
http://dx.doi.org/10.1186/s12951-019-0451-9

Ejemplares similares